Clinical Trial Update: REGistry of Long-term AnTithrombotic TherApy-2

View source ↗

Summary

A registry entry indicates the REGistry of Long-term Antithrombotic Therapy-2 trial in atrial fibrillation is currently recruiting in Russia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Conditions: Atrial Fibrillation | Status: RECRUITING